Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_assertion type Assertion NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_head.
- NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_assertion description "[To investigate the underlying mechanisms of the cell-specific response to retinoids, we transfected ET-1 promoter constructs containing wild-type or mutated AP-1 or GATA-2 site into prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_provenance.
- NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_assertion evidence source_evidence_literature NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_provenance.
- NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_assertion SIO_000772 9809984 NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_provenance.
- NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_assertion wasDerivedFrom befree-2016 NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_provenance.
- NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_assertion wasGeneratedBy ECO_0000203 NP1407816.RA3_CMp6W1DfYQxDLvEe8-DExAFdNvpYArGP_WF4D15Ec130_provenance.